As we work towards the January 25, 2023 effective date of the new NIH Data Management and Sharing (DMS) Policy, we continue to develop resources and implementation information to help the community prepare. We will be supporting you with additional resources and guidance through the change.
Last summer, we reported that in fiscal year 2020 NIH supported 1,412 early-stage investigators (ESIs) as first-time Principal Investigators on R01-equivalent awards. This all-time high was seen after several years of steady growth in the number of ESIs supported since implementing NIH’s Next Generation Researchers Initiative five years ago. Today, we take a look specifically at how ESIs and other targeted groups fared last fiscal year.
3 Comments
I am pleased to announce the appointment of Dr. Ericka Boone as the new director of the Division of Biomedical Research Workforce (DBRW) in the NIH Office of Extramural Research (OER), and I am thrilled she agreed to take on this role, given her background, interest, passions, and work ethic. Read on to learn more about Ericka.
2 Comments
Here we discuss how inflation has been relevant to NIH Research Project Grants (RPG), the largest component of extramural NIH funding.
19 Comments
In earlier posts, we looked at the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we extend on our prior analyses by presenting R01-equivalent application data on PI characteristics of Early Stage Investigators (ESIs).
4 Comments
NIH has long collected self-designated demographic information on scientists designated as Principal Investigators (PIs) or Key Personnel and used this information to gain insights into the NIH-supported biomedical research workforce.
44 Comments
Today we discuss what you and your institution should consider when submitting the same applications to multiple funders.
4 Comments
It’s worth reflecting that it has been more than two years since the COVID-19 pandemic began. Let’s look back to the months of early to mid-2020 when the nation (and the rest of the world) faced a “novel” coronavirus, one which we knew could be fatal and for which there was little knowledge about how it spreads and no known effective treatment, limited diagnostic tests, and no vaccine. How did NIH make fast and meaningful contributions to respond to the pandemic?
0 Comments
The recently passed Consolidated Appropriations Act for fiscal year 2022 includes “Section 239,” which is a milestone in our efforts to ensure safe working conditions for people engaged in NIH-supported research. The law requires NIH grant recipients to notify us when their senior key personnel are removed from their position or are otherwise disciplined due to concerns about harassment, bullying, retaliation, or hostile working conditions. This is a major step in our continued effort to change the culture of harassment in biomedical science.
16 Comments
Our annual snapshot of how many researchers NIH supports on research project Grants, R01-equivalent Grants, P01 Grants, and R21 Grants is back.
0 Comments
1 Comments